Call (844) 879-2237

Home » News
Post Image

Acera’s SAWC 2017 Poster

Read More

Acera Surgical Publishes Manuscript Highlighting the Mechanism of Action of Nanofabricated Restrata™ Wound Matrix

St. Louis, MO— October 5th, 2017— Acera Surgical Inc., a bioscience company dedicated to the commercialization of fully synthetic electrospun scaffolds for regenerative medical applications, announced today the publication of scientific manuscript describing the mechanism of action of the Restrata™ […]

Read More

Acera to Start Clinical Trial on Restrata™ Wound Matrix

St. Louis, MO. September 15, 2017- Acera is starting a clinical trial on Restrata™ Wound Matrix with a focus on diabetic foot ulcer.  Acera will be working with Telos Partner to manage the clinical trial. The study is titled: “Clinical Outcomes […]

Read More

Acera Surgical Announces Publication of Pre-Clinical Study on Restrata™

St. Louis, MO—September 5, 2017— Acera Surgical Inc., a company dedicated to the development and commercialization of fully synthetic electrospun scaffolds for regenerative medical applications, announced today the publication of results from the pre-clinical study of the efficacy of Restrata […]

Read More

Acera Surgical to Present Results of Study on the Use of Restrata™ Wound Matrix in Healing Full-thickness Wounds at Fall Symposium on Advanced Wound Care

St. Louis, MO—August 29, 2017— Acera Surgical Inc., a pioneer in regenerative medicine, has been selected to present the results from a study involving the Restrata™ Wound Matrix at the Fall 2017 Symposium on Advanced Wound Care (“SAWC”), being held in […]

Read More

Acera Surgical’s advanced wound care product, the Restrata™ Wound Matrix, gains FDA Approval

Acera Surgical Inc., (“Acera”) a bioscience company located in St. Louis, MO received 510(k) clearance from the Food and Drug Administration (FDA) for its innovative wound care product, the Restrata™ Wound Matrix on April 26th. Restrata™ is a fully-synthetic electrospun wound […]

Read More

Acera Surgical Receives FDA Clearance for Nanofabricated Tissue Scaffold

ST.LOUIS – Acera Surgical, Inc., a Washington University startup co-founded by former WU student Dr. Matthew MacEwan, received 510(k) clearance from the Food and Drug Administration (FDA) for its first clinical product, the Cerafix® Dura Substitute. With the approval from […]

Read More

ACERA Selected as One of the “Best University Startups 2016” by National Council of Entrepreneurial Tech Transfer

Acera Surgical has been selected as one of the “Best University Startups 2016” by National Council of Entrepreneurial Tech Transfer (NCET2).
NCET2 recognizes that Startup Officers are the backbone of any university’s research commercialization program. They work to support the world’s most […]

Read More

ACERA Selected to Present at the 2016 Texas Lifescience Venture Forum May 26th, 2016 in Houston, TX

Acera Surgical has been selected to present at the 2016 Texas Life Science Venture Forum in Houston, Texas on May 26th, 2016.
Texas Life Science Forum is the premiere life science venture conference in the Southwest. The Forum is the most comprehensive showcase and […]

Read More

ACERA Selected to Present at the 2015 Texas Lifescience Venture Forum May 20th, 2015 in Houston, TX

 
Acera Surgical has been selected to present at the 2015 Texas Life Science Venture Forum in Houston, Texas on May 20th, 2015.
Texas Life Science Forum is the premiere life science venture conference in the Southwest. The Forum is the most comprehensive showcase and […]

Read More
http://acera-surgical.com